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Depression is one of the most common 
and serious mental disorders. According 
to the Global Burden of Disease Study of 
the WHO, it is one of the main causes of 
disease-related disability worldwide [1] 
and accounts for a large part of the global 
disease burden [2]. Due to its high prev-
alence and far-reaching consequences for 
individuals and society as a whole, de-
pression and the care for those affected by 
it are of major public health relevance [1, 
3]. The general term depression is used to 
describe a wide clinical spectrum, rang-
ing from isolated depressive symptoms, 
through light or subthreshold forms of 
depressive disorder, to severe major de-
pressive disorder [3]. Subthreshold de-
pressive symptoms are already of great 
relevance in this context. Even if they do 
not meet the criteria of a clinical disor-
der, they are often associated with impair-
ment and an increased risk for the devel-
opment of major depression.
Reliable information at the popula-
tion level is needed to estimate the dis-
ease burden of depression and associat-
ed care needs in Germany. DEGS1, the 
first wave of the German Health Inter-
view and Examination Survey for Adults 
(“Studie zur Gesundheit Erwachsener in 
Deutschland”, DEGS), provides repre-
sentative up-to-date data on the preva-
lence of depression in the general popu-
lation aged 18–79 years [4]. For this, sev-
eral aspects of depression are assessed 
in DEGS1 that need to be differentiated 
from one another in terms of their con-
tent (. Tab. 1, [5]). In a written ques-
tionnaire, current depressive symptoms 
are assessed with a self-reported depres-
sion rating scale that is a well-established 
screening tool for depression in clinical 
practice [6] and a measure for depressive 
symptoms in health surveys [7]. Previ-
ously diagnosed depression is assessed by 
physician interview [5], thus allowing to 
estimate the diagnosis prevalence within 
the healthcare system and to compare it 
with other countries [7]. In addition, the 
mental health module (DEGS1-MH) as-
sesses depressive disorders based on the 
established clinical criteria of the DSM-
IV and ICD-10 diagnostic systems using 
a standardised diagnostic interview [5, 8].
This paper presents the findings of 
DEGS1 on the prevalence of depressive 
symptoms and diagnosed depression 
among adults in Germany 18–79 years 
old.
Methods
Study design and sample
The German Health Interview and Exam-
ination Survey for Adults (DEGS) is part 
of the health monitoring programme at 
the Robert Koch Institute (RKI). The con-
cept and design of DEGS are described in 
detail elsewhere [5, 9, 10, 11, 12]. The first 
data collection wave (DEGS1) was con-
ducted from 2008–2011 and comprised 
interviews, examinations and tests [4, 13]. 
The target population included residents 
of Germany aged 18–79 years. DEGS1 
has a mixed design which permits both 
cross-sectional and longitudinal anal-
yses. For this purpose, a random sam-
ple from local population registries was 
drawn to supplement former participants 
from the German National Health Inter-
view and Examination Survey 1998 (GN-
HIES98). A total of 8,152 persons partic-
ipated, including 4,193 first-time partici-
pants (response rate 42%) and 3,959 for-
mer participants of GNHIES98 (response 
rate 62%). There were 7,238 persons who 
visited one of the 180 examination cen-
tres, and 914 were interviewed only. The 
net sample permits representative cross-
sectional analyses for the age range of 18–
79 years (n=7,988, including 7,116 in ex-
amination centres) and time trend anal-
yses based on comparison with GN-
HIES98 [11]. The cross-sectional analy-
sis presented here refers to the sample of 
7,988 persons aged 18–79 years who took 
part in the interviews [11].
Depressive symptoms
Current depressive symptoms were as-
sessed with a written, self-administered 
questionnaire [5, 13] using the depression 
module of the German version of the Pa-
tient Health Questionnaire (PHQ) [6, 14]. 
The depression module (PHQ-9) is a self-
assessment instrument for measuring the 
presence and frequency of nine depres-
sive symptoms within the last 2 weeks 
based on the diagnostic criteria for “ma-
Main topic
1Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 5/6 · 2013  | 
jor depression” as defined in DSM-IV (lit-
tle interest or pleasure, depressed mood, 
sleep disturbances, tiredness or little en-
ergy, poor appetite or overeating, feelings 
of worthlessness or guilt, trouble concen-
trating, psychomotor retardation or ag-
itation, suicidal thoughts). Depending 
on the reported frequency of symptoms, 
scores of 0 (“not at all”), 1 (“several days”), 
2 (“more than half the days”) or 3 (“near-
ly every day”) points are assigned to each 
item. Item scores are summed for the 
PHQ-9 total score, which ranges from 0 
and 27 points. A total score of 10 or more 
points indicates current depressive symp-
toms [6, 14].
Diagnosed depression
In the standardised, computer-assisted 
personal interview (CAPI) conducted by 
a study physician [5, 13], previously diag-
nosed depression was assessed by asking 
the question: “Have you ever been diag-
nosed with depression by a physician or a 
psychotherapist?” If they answered “yes”, 
the participants were additionally asked 
whether they had been diagnosed with 
depression during the last 12 months: 
“Was the depression present during the 
past 12 months?”
Covariables
Socioeconomic status (SES) was deter-
mined using an index which was based 
on information from the written ques-
tionnaire on school education and voca-
tional training, occupational status and 
net household income (need-weighted), 
permitting classification into low, medi-
um and high status groups [15].
The size of municipality was defined 
using the official administrative munici-
pal code for the place of residence to as-
sign the latter to the following aggregat-
ed categories for municipality size: rural 
(<5,000 inhabitants), small town (5,000 
to <20,000 inhabitants), medium-sized 
town (20,000 to <100,000) and large town 
(≥100,000 inhabitants) [11].
Statistical analysis
The point prevalence of current de-
pressive symptoms and the lifetime and 
12-month prevalence of diagnosed de-
pression were calculated as percentages 
with 95% confidence intervals (95% CI) 
of the total numbers of all participants 
who gave valid answers. Participants who 
provided no or incomplete answers to the 
PHQ-9 and those who gave no answer or 
replied “Don’t know” to the questions 
on diagnosed depression were excluded 
from the relevant analyses.
Associations between the above preva-
lences and age group, sex, SES and size of 
municipality were examined using logis-
tic regression analyses. Differences were 
considered statistically significant if p val-
ues were <0.05.
A weighting factor was used for all 
analyses which corrects sample devia-
tions from population structure (as of 
31 Dec 2010) with regard to age, sex, re-
gion, nationality, type of municipality and 
education [11]. Calculation of the weight-
ing factor for the former participants in 
GNHIES98 took account of the probabili-
ty of repeated participation based on a lo-
gistic regression model. A non-responder 
analysis and a comparison of selected in-
dicators with data from official statistics 
indicate that the sample is highly repre-
sentative of the resident population aged 
18–79 years in Germany [11].
In order to take account of both the 
weighting and the correlation of partic-
ipants within a sample point, confidence 
intervals and p values were calculated us-
ing survey procedures in Stata 12.1.
Tab. 2 Prevalence of current depressive symptoms (PHQ-9 ≥10 points) by sex and age 
























































Tab. 1 Assessment of depression in DEGS1
Aspect of depression Study part Instrument Commentary
Depressive symptoms Self-administered ques-
tionnaire
PHQ-9 Dimensional assessment of the frequency of nine depressive symptoms 
during the last 2 weeks; quantification of depression severity based on a 





PHQ-9 Category-based assessment of depressive symptoms with more than one 
depressive symptom during the last 2 weeks; derived from the PHQ-9 
total score through dichotomisation at the cut-off ≥10 points
Diagnosed depression Physician interview Closed question: 
“Has a physician or 
psychotherapist ever 
diagnosed you with 
depression?”
Self-report of a previous diagnosis of depression in the past and during 
the last 12 months
Depressive disorders Mental Health module 
(DEGS1-MH)
CIDI interview Diagnosis of a depressive disorder based on the criteria of the clinical 
diagnostic systems DSM-IV and ICD-10
PHQ-9 Depression module of the Patient Health Questionnaire, CIDI Composite International Diagnostic Interview, DSM-IV Diagnostic and Statistical Manual of Mental 





The full version of the written question-
naire was completed by 7,807 partici-
pants (97.7% of the 7,988 participants). 
Complete PHQ-9 data were available for 
7,524 of these respondents (96.4%): 3,940 
women and 3,584 men.
Current depressive symptoms (PHQ-
9 score ≥10 points) are present in 8.1% of 
adults aged 18–79 years (. Tab. 2), with 
women (10.2%) showing a significant-
ly higher prevalence than men (6.1%) 
(p<0.0001). Prevalence is highest in the 
age group from 18–29 years (11.8 and 8.0%) 
and decreases thereafter. This decrease in 
prevalence with increasing age is statisti-
cally significant overall (pTrend=0.01) and 
among men (pTrend=0.02) but not among 
women (pTrend=0.09). The lowest preva-
lence is found among women and men 
aged 70–79 years (7.7 and 4.2%). Wom-
en show a higher prevalence than men in 
all age groups.
Overall, there is an inverse relationship 
between socioeconomic status and the 
prevalence of current depressive symp-
toms (. Tab. 4). The prevalence among 
persons with low SES (13.6%) is almost 
twice as high as among those with high 
SES (4.6%, pTrend<0.0001). This social 
gradient is more marked among wom-
en than men (pTrend<0.0001 in each case).
With regard to size of municipality, 
the lowest overall prevalence of current 
depressive symptoms is found among 
persons who live in small towns (5.8%, 
95% CI 4.7–7.1), compared to persons 
from large towns (9.4%, 95% CI 7.6–
11.6, p=0.03), medium-sized towns (9.1%, 
95% CI 7.5–11.0, p=0.02) and rural areas 
(7.4%, 95% CI 6.0–9.1, p=0.8). This rela-
tionship is similar for men and women 
and also remains after statistical adjust-
ment for age, sex and SES.
Diagnosed depression
Data from the CAPI on previously diag-
nosed depression were available for 7,912 
participants (99.1%): 4,146 women and 
3,766 men. Of these, 7,900 (99.9%) also 
provided details regarding diagnosed de-
pression during the previous 12 months.
The overall lifetime prevalence of di-
agnosed depression is 11.6% (. Tab. 3). 
Women (15.4%) report a previously di-
agnosed depression almost twice as fre-
quently as men with 7.8% (p<0.0001). 
Lifetime prevalence increases with in-
creasing age and is highest among wom-
en and men aged 60–69 years (22.9 and 
11.6%), after which it falls again. The low-
est prevalence is found among young 
adults aged 18–29 years (8.5 and 4.2%). 
Compared to the 60–69 year olds, prev-
alence levels are lower overall (p≤0.001 in 
each case) in all other age groups with the 
exception of the 50–59 year olds.
A total of 6.0% of participants report 
diagnosed depression during the previous 
12 months, and here again the prevalence 
is around twice as high among women 
(8.1% versus 3.8% for men, p<0.0001). 
The 12-month prevalence among women 
and men is also lowest in the age group 
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Abstract
In the German Health Interview and Exam-
ination Survey (DEGS1), current depressive 
symptoms were assessed with the Patient 
Health Questionnaire (PHQ-9) in a repre-
sentative population-based sample of 7,988 
adults 18–79 years old. In addition previously 
diagnosed depression was assessed by phy-
sician interview. The prevalence of current 
depressive symptoms (PHQ-9 ≥10 points) is 
8.1% (women 10.2%; men 6.1%). For both 
sexes, the prevalence is highest among 18- 
to 29-year-olds and decreases with age. Per-
sons with higher socioeconomic status (SES) 
are less likely to have current depressive 
symptoms. The lifetime prevalence of diag-
nosed depression is 11.6% (women 15.4%; 
men 7.8%) and is highest among persons 
60–69 years old. The 12-month prevalence is 
6.0% (women 8.1%; men 3.8%) and is highest 
among 50–59 year olds. In women, but not 
in men, prevalences decrease with increasing 
SES. The results describe the distribution of 
two important aspects of depression among 
the adult population in Germany and confirm 
previously observed associations with age, 
gender and SES.
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Prävalenz von depressiver Symptomatik und diagnostizierter 
Depression bei Erwachsenen in Deutschland. Ergebnisse der 
Studie zur Gesundheit Erwachsener in Deutschland (DEGS1)
Zusammenfassung
In der Studie zur Gesundheit Erwachsener in 
Deutschland (DEGS1) wurden von 2008 bis 
2011 in einer bevölkerungsrepräsentativen 
Stichprobe von 7988 Personen im Alter von 
18 bis 79 Jahren aktuelle depressive Symp-
tome mit dem „Patient Health Questionnaire“ 
(PHQ-9) erfasst. Zusätzlich wurden diagnosti-
zierte Depressionen in einem ärztlichen In-
terview erfragt. Eine depressive Symptoma-
tik (PHQ-9 ≥10 Punkte) besteht bei 8,1% der 
Erwachsenen (Frauen 10,2%; Männer 6,1%). 
Bei beiden Geschlechtern ist die Prävalenz 
bei 18- bis 29-Jährigen am höchsten und 
fällt danach ab. Bei Männern und Frauen mit 
höherem sozioökonomischem Status be steht 
seltener eine depressive Symptomatik. Die 
Lebenszeitprävalenz einer diagnostizierten 
Depression beträgt 11,6% (Frauen 15,4%; 
Männer 7,8%) und ist am höchsten bei 60- 
bis 69-Jährigen; die 12-Monats-Prävalenz 
liegt bei 6,0% (Frauen 8,1%; Männer 3,8%) 
und ist am höchsten bei 50- bis 59-Jährigen. 
Bei Frauen, aber nicht bei Männern sinken die 
Diagnoseprävalenzen mit steigendem sozio-
ökonomischem Status. Die Ergebnisse be-
schreiben die weite Verbreitung von depres-
siver Symptomatik und diagnostizier ter De-
pression in der Erwachsenenbevölke rung 
in Deutschland und bestätigen bekannte 
Zusammenhänge von Depression mit Alter, 
Geschlecht und sozioökonomischem Status.
Schlüsselwörter
Depressive Symptomatik · Depression ·  
Prävalenz · Gesundheitssurvey · Bevölkerung
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from 18–29 (5.1 and 2.1%), thereafter 
steadily increasing to the highest prev-
alence levels among the 50–59 year olds 
(10.9 and 6.0%) before falling again. On 
the whole, prevalence levels are signifi-
cantly lower in all age groups (apart from 
the 60–69 year olds) relative to the 50–
59 year olds.
Women show an inverse relation-
ship between socioeconomic status and 
the lifetime and 12-month prevalence of 
diagnosed depression (. Tab. 4). Both 
prevalences decrease significantly with 
rising SES (pTrend=0.01 and <0.0001), 
and the difference is particularly marked 
between women with high and wom-
en with medium or low SES. At 12.9%, 
the 12-month prevalence among women 
with low SES is more than twice as high 
as among women with high SES. In con-
trast, no clear social gradient is found 
among men. The age group-specific anal-
ysis shows a social gradient among men 
in the middle age groups (40–59 years) 
but not below the age of 40 or above the 
age of 59 years.
Overall, the lifetime and 12-month 
prevalence of diagnosed depression are 
highest in large towns (13.7 and 7.6%), 
followed by mid-sized towns (11.4 and 
5.5%) and rural areas (10.5 and 5.7%), 
while they are lowest in small towns (9.9 
and 4.4%). The significant association 
between 12-month prevalence and size of 
municipality is found in equal measure 
among men and women, whereas with 
regard to lifetime prevalence it is only 
found with women.
Discussion
The results of DEGS1 presented here 
make a contribution towards estimating 
the care needs and disease burden due to 
depression in Germany. The results pro-
vide up-to-date information on the prev-
alence and distribution of two important 
aspects of depression among the adult 
population. The last time representative 
nationwide data were collected on the 
prevalence of depressive disorders in the 
German adult population was in the con-
text of the mental health module of the 
German National Health Interview and 
Examination Survey 1998 (GNHIES98) 
which included persons aged 18–65 years 
[16]. The current data from DEGS1 ex-
tend the GNHIES98 findings by also in-
cluding older people up to the age of 79 
in the assessment of mental health; it al-
so includes information from all partici-
pants in the main survey about two ad-
ditional key indicators for depression 
that are well-established in international 
health surveys.
Depressive symptoms
To date, no comparative data for Ger-
many are available on the prevalence of 
current depressive symptoms among the 
general adult population. However, the 
National Health and Nutrition Exami-
nation Survey (NHANES) and the Be-
havioral Risk Factor Surveillance System 
(BRFSS) in the USA have been recording 
current depressive symptoms for many 
years using the PHQ-9 with a cut-off of 
≥10 points [7]. The measured point prev-
alences of 6.8% (NHANES 2005–2008) 
and 8.7% (BRFSS 2006) are similar to the 
overall prevalence of 8.1% now recorded 
by DEGS1. The differences between men 
and women are also of similar magni-
tudes (BRFSS 10.5 and 6.8% [17], DEGS1 
10.2 and 6.1%). Moreover, the prevalence 
measured by the BRFSS has been stable 
for a number of years [7].
Tab. 4 Prevalence of current depressive symptoms (PHQ-9 ≥10 points) and diagnosed 
depression (lifetime and 12-month prevalence) by sex and socioeconomic status (SES) in 
percent (95% confidence interval)
  Low SES Medium SES High SES
Current depressive symptoms (n=7,876)
Women 16.0 (12.7–19.9) 9.9 (8.3–11.7) 5.0 (3.5–7.0)
Men 11.1 (8.1–15.0) 5.3 (4.3–6.5) 4.3 (2.9–6.3)
Total 13.6 (11.2–16.5) 7.6 (6.6–8.8) 4.6 (3.6–6.0)
Diagnosed depression: lifetime prevalence (n=7,800)
Women 19.8 (16.2–24.0) 14.3 (12.6–16.1) 13.9 (11.7–16.5)
Men 8.8 (6.2–12.2) 7.6 (6.3–9.2) 6.6 (5.0–8.8)
Total 14.5 (12.1–17.3) 11.0 (9.9–12.3) 9.9 (8.5–11.4)
Diagnosed depression: 12-month prevalence (n=7,789)
Women 12.9 (9.7–17.0) 7.0 (5.9–8.4) 5.5 (3.8–8.1)
Men 3.7 (2.2–6.2) 3.6 (2.7–4.8) 3.7 (2.3–5.7)
Total 8.5 (6.6–10.9) 5.4 (4.6–6.3) 4.5 (3.4–6.0)
Tab. 3 Lifetime prevalence and 12-month prevalence of diagnosed depression by sex and 















































































































The use of different assessment instru-
ments makes it difficult to compare the 
prevalence of diagnosed depression 
found in DEGS1 with the prevalence of 
depression in the mental health mod-
ule of GNHIES98 (GNHIES98-MH). In 
GNHIES98-MH, depressive disorders 
were diagnosed using the standardised 
CIDI interview that is based on diagnos-
tic criteria. The 12-month prevalence of 
depression was estimated at 11% in wom-
en and 6% in men aged 18–65 years [16]. 
The slightly lower prevalence in DEGS1 
based on self-reports of previously diag-
nosed depression may be due to the fact 
that non-diagnosed depression was not 
recorded and that some participants with 
diagnosed depression did not report it. As 
a result, the estimates for the prevalence 
of depression based on the DEGS1 ques-
tion on diagnosed depression should be 
considered conservative compared to the 
findings of diagnostic interviews, as on-
ly reported cases of previously diagnosed 
depression are captured. Other stud-
ies have estimated the overall 12-month 
prevalence of major depression at 6.9% in 
Europe (without evidence for an increase 
or decrease between 2005 and 2011) [18] 
and 6.6% in the USA [19]. The mental 
health module of DEGS1 (DEGS1-MH), 
in which depressive disorders were also 
diagnosed using a standardised CIDI in-
terview (. Tab. 1, [8]), allows compari-
sons of DEGS1 with GNHIES98-MH and 
international data.
The high level of agreement between 
DEGS1 results and findings of the study 
German Health Update (GEDA) 2009, 
however, indicates that the prevalence 
of diagnosed depression is a robust in-
dicator of depression. In GEDA, diag-
nosed depression was assessed using a 
question similar to that in DEGS1 [20]. 
The 12-month prevalence of 8% in wom-
en and 4.5% in men is very close to the 
prevalence found in DEGS1 at a similar 
survey time.
An analysis of the prevalence of di-
agnosed depression in ambulatory care 
based on claims data for all people in 
Germany with statutory health insur-
ance in 2007 showed a 12-month prev-
alence of 10.2%, higher than the preva-
lence found in DEGS1 [21]. However, this 
analysis did not specify an upper age lim-
it and the age-specific prevalence showed 
two peaks, with an additional marked in-
crease among people over the age of 80. 
Furthermore, the study design of DEGS1 
probably means that people with acute se-




The prevalences of current depressive 
symptoms and diagnosed depression 
are both clearly associated with age but 
show different characteristic age-related 
patterns. The finding that the prevalence 
of current depressive symptoms is high-
est among young adults and then steadi-
ly decreases with increasing age confirms 
the results of the BRFSS health survey in 
the USA [17]. It is also known from oth-
er surveys that the lifetime and 12-month 
prevalence of diagnosed depression ini-
tially rises in younger adults, is highest 
between the ages of 50 and 69 and then 
falls again as people get older [17, 20]. 
These age-related effects may partly be 
explained by the differential impact of 
stress and resilience factors in different 
age groups as well as biographical influ-
ences [3, 22]. Moreover, old age is often 
associated with atypical types of depres-
sion (e.g. with physical symptoms playing 
a key role) that are less likely to be detect-
ed by the assessment instruments used in 
DEGS1 and that are also diagnosed less 
frequently in clinical practice [3, 23]. In 
addition, the possibility of an age-related 
information bias cannot be ruled out, as 
a result of older people remembering, ex-
periencing or reporting depressive symp-
toms and disorders less frequently than 
their younger counterparts [3, 22].
Several German and international 
studies have shown a higher prevalence 
of depressive disorders and depressive 
symptoms among women overall and 
in specific age groups [3, 7, 16, 19, 20, 21, 
24]. These findings are also confirmed by 
DEGS1. The difference between the sex-
es is probably due to a variety of differ-
ent neurobiological, hormonal, psycho-
social, behaviour-related and other fac-
tors as well as differences in the percep-
tion and communication of depressive 
symptoms [3, 25, 26].
Low socioeconomic status is asso-
ciated with an increased risk of depres-
sion and other mental disorders [24, 27, 
28]. This relationship has previously been 
shown for Germany by GNHIES98-MH 
[16] and GEDA2009 [20] and is now re-
confirmed by the results of DEGS1.
The aforementioned analysis of claims 
data for ambulatory care in 2007 also 
showed that the type of residential region 
influenced the prevalence of diagnosed 
depression, irrespective of age, sex and 
socioeconomic status [21]. As in DEGS1, 
prevalence was highest in large towns, but 
high prevalences were also found in ru-
ral regions.
Strengths and limitations
DEGS1 is a nationwide study that is rep-
resentative of the general population and 
that allows generalisations on the distri-
bution of depression among adults living 
in Germany. Further analyses will use ad-
ditional health-related data from DEGS1 
to examine the influence of risk and pro-
tective factors for depression, health ef-
fects of depressive symptoms and diag-
nosed depression, and the resulting care 
needs.
An important limitation of this study 
is that the data presented here are based 
on self-reports provided by the partici-
pants. It will be possible, however, to ver-
ify and supplement the collected data on 
depressive symptoms and diagnosed de-
pression in further analyses by using data 
from the diagnostic interview in DEGS1-
MH [8]. Moreover, it can be assumed that 
persons with current severe depression 
are underrepresented in the study sam-
ple. As a result, the prevalence estimates 
reported here are to be seen as conserva-
tive. As the assessment instruments used 
in DEGS1 were not used in GNHIES98, 
it is not possible to examine prevalence 
trends over time. As mentioned above, 
this gap will be filled by trend analy-
ses and longitudinal analyses using da-
ta from DEGS1-MH. Due to the differ-
ences in the assessed aspects of depres-
sion and the assessment instruments in 
DEGS1 and DEGS1-MH, clear differenc-
es are to be expected in the resulting esti-
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mates for prevalence and distribution of 
depression in the population. Although 
the assessed aspects are closely related, 
the corresponding prevalences cannot be 














Robert Koch Institute,  
Department of Epidemiology and  
Health Monitoring
General-Pape-Str. 62–66, 12101 Berlin
Germany
BuschM@rki.de
Funding of the study. The study was financed by 
the Robert Koch Institute and the Federal Ministry of 
Health.
Conflict of interest. On behalf of all authors, 
the corresponding author states that there are  
no conflicts of interest.
References
 1. Vos T, Flaxman AD, Naghavi M et al (2013) Years 
lived with disability (YLDs) for 1160 sequelae of 
289 diseases and injuries 1990–2010: a systemat-
ic analysis for the Global Burden of Disease Study 
2010. Lancet 380:2163–2196
 2. Murray CJL, Vos T, Lozano R et al (2012) Disability-
adjusted life years (DALYs) for 291 diseases and in-
juries in 21 regions, 1990–2010: a systematic anal-
ysis for the Global Burden of Disease Study 2010. 
Lancet 380:2197–2223
 3. Wittchen HU, Jacobi F, Klose M, Ryl L (2010) De-
pressive Erkrankungen. Gesundheitsberichterstat-
tung des Bundes, Heft 51. Robert Koch-Institut, 
Berlin
 4. Robert Koch-Institut (eds) (2009) DEGS: Studie 
zur Gesundheit Erwachsener in Deutschland – 
Projekt beschreibung. Beiträge zur Gesundheits-
berichterstattung des Bundes. Robert Koch-Insti-
tut, Berlin
 5. Scheidt-Nave C, Kamtsiuris P, Gößwald A et al 
(2012) German Health Interview and Examination 
Survey for Adults (DEGS)—design, objectives and 
implementation of the first data collection wave. 
BMC Public Health 12:730
 6. Löwe B, Spitzer RL, Zipfel S, Herzog W (2002) Ge-
sundheitsfragebogen für Patienten (PHQ-D). 
Komplettversion und Kurzform. Testmappe mit 
Manual, Fragebögen, Schablonen. 2nd edn. Pfizer, 
Karlsruhe
 7. Reeves WC, Strine TW, Pratt LA et al (2011) Men-
tal illness surveillance among adults in the United 
States. MMWR Surveill Summ 60(Suppl 3):1–29
 8. Jacobi F, Mack S, Gerschler A et al (2013) The de-
sign and methods of the mental health module 
in the German Health Interview and Examination 
Survey for Adults (DEGS1-MH). Int J Methods Psy-
chiatr Res (in press)
 9. Kurth BM, Lange C, Kamtsiuris P, Hölling H (2009) 
Health monitoring at the Robert Koch-Institute. 
Status and perspectives. Bundesgesundheits-
blatt Gesundheitsforschung Gesundheitsschutz 
52:557–570
10. Kurth BM (2012) Das RKI-Gesundheitsmonitoring 
– was es enthält und wie es genutzt werden kann. 
Public Health Forum 20(76):4.e1–4.e3
11. Kamtsiuris P, Lange M, Hoffmann R et al (2013) 
The first wave of the German Health Interview 
and Examination Survey for Adults (DEGS1). Sam-
pling design, response, sample weights, and rep-
resentativeness. Bundesgesundheitsblatt Gesund-
heitsforschung Gesundheitsschutz 56:620–630
12. Gößwald A, Lange M, Kamtsiuris P, Kurth BM 
(2012) DEGS: German Health Interview and Exam-
ination Survey for Adults. A nationwide cross-sec-
tional and longitudinal study within the frame-
work of health monitoring conducted by the Ro-
bert Koch Institute. Bundesgesundheitsblatt Ge-
sundheitsforschung Gesundheitsschutz 55:775–
780
13. Gößwald A, Lange M, Dölle R, Hölling H (2013) 
The first wave of the German Health Interview 
and Examination Survey for Adults (DEGS1). Parti-
cipant recruitment, fieldwork, and quality man-
agement. Bundesgesundheitsblatt Gesundheits-
forschung Gesundheitsschutz 56:611–619
14. Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-
9: validity of a brief depression severity measure. J 
Gen Intern Med 16:606–613
15. Lampert T, Kroll L, Müters S, Stolzenberg H (2013) 
Measurement of socioeconomic status in the Ger-
man Health Interview and Examination Survey 
for Adults (DEGSS1). Bundesgesundheitsblatt Ge-
sundheitsforschung Gesundheitsschutz 56:631–
636
16. Jacobi F, Wittchen HU, Holting C et al (2004) Prev-
alence, co-morbidity and correlates of mental dis-
orders in the general population: results from the 
German Health Interview and Examination Survey 
(GHS). Psychol Med 34:597–611
17. Strine TW, Mokdad AH, Balluz LS et al (2008) De-
pression and anxiety in the United States: findings 
from the 2006 Behavioral Risk Factor Surveillance 
System. Psychiatr Serv 59:1383–1390
18. Wittchen HU, Jacobi F, Rehm J et al (2011) The size 
and burden of mental disorders and other disor-
ders of the brain in Europe 2010. Eur Neuropsy-
chopharmacol 21:655–679
19. Kessler RC, Berglund P, Demler O et al (2003) The 
epidemiology of major depressive disorder: re-
sults from the National Comorbidity Survey Repli-
cation (NCS-R). JAMA 289:3095–3105
20. Busch M, Hapke U, Mensink GBM (2011) 
 Psychische Gesundheit und gesunde Lebens-
weise. GBE kompakt 2(7). Robert Koch-Intitut, 
Berlin
21. Erhart M, Stillfried D von (2012) Analyse regiona-
ler Unterschiede in der Prävalenz und Versorgung 
depressiver Störungen auf Basis vertragsärztli-




22. Mauz E, Jacobi F (2008) Psychische Störungen 
und soziale Ungleichheit im Geburtskohortenver-
gleich. Psychiatr Prax 35:343–352
23. Weyerer S, Bickel H (2007) Epidemiologie depres-
siver Erkrankungen und suizidaler Handlungen. 
In: Weyerer S, Bickel H (eds) Epidemiologie psy-
chischer Erkrankungen im höheren Lebensalter. 
Kohlhammer, Stuttgart, pp 115–136
24. Bromet E, Andrade L, Hwang I et al (2011) Cross-
national epidemiology of DSM-IV major depres-
sive episode. BMC Med 9:90
25. Kuehner C (2003) Gender differences in unipolar 
depression: an update of epidemiological findings 
and possible explanations. Acta Psychiatr Scand 
108:163–174
26. Noble RE (2005) Depression in women. Metabo-
lism 54:49–52
27. Lorant V, Deliège D, Eaton W et al (2003) Socioeco-
nomic inequalities in depression: a meta-analysis. 
Am J Epidemiol 157:98–112
28. WHO International Consortium in Psychiatric Epi-
demiology (2000) Cross-national comparisons of 
the prevalences and correlates of mental disor-
ders. Bull World Health Organ 78:413–426
6
Main topic
|  Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 5/6 · 2013
